Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.…
CORRECTION -- ProLogium and TDAC Announce Prospective Investments of $135 Million
Translational Development Acquisition (NASDAQ: TDAC) is listed on Nasdaq, where its shares trade in USD. It belongs to the Shell Companies industry, part of the Financial Services sector.
The shares were at 10.92 USD on 20 November 2026, up 4.9% over 52 weeks. Its 52-week range is 10.41 USD to 10.95 USD, and it trades at the top of that range.
Its market capitalisation is 210.85M USD.
Translational Development Acquisition reports return on equity of 3.6% and an operating margin of 0.0%.
Its debt exceeds its cash by 1.01M USD, a debt-to-equity ratio of 0.00. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.
No upcoming events tracked.